To determine the critical and optimal stage of complement overactivation in the APP/PS1 brain, we first evaluated the level of complement C3, its activated fragment (C3b) and its inhibitor FH using total brain protein extractions at 6 to 15 months, ages at which the vascular damages progress in this AD murine model [31,32]. This evidence concerns the gene FH and Alzheimer disease.